61 – 70 of 143
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2011
-
Mark
Induction of Auto-Antibodies Against β(2) -Glycoprotein I in Mice by Protein H of Streptococcus Pyogenes.
(
- Contribution to journal › Article
-
Mark
Recombinant human factor VIIa (rFVIIa) cleared principally by antithrombin following IV administration in haemophilia patients.
(
- Contribution to journal › Article
-
Mark
Succinate independently stimulates full platelet activation via cAMP and PI3β kinase signaling.
(
- Contribution to journal › Article
-
Mark
Safety and pharmacokinetics of subcutaneously administered recombinant activated factor VII (rFVIIa).
(
- Contribution to journal › Article
-
Mark
A Randomized Clinical Trial of Prophylaxis in Children with Hemophilia A (the ESPRIT Study).
(
- Contribution to journal › Article
-
Mark
Effects of the oral, direct factor Xa inhibitor rivaroxaban on commonly used coagulation assays.
(
- Contribution to journal › Article
-
Mark
Thirty-years' experience of prenatal diagnosis of haemophilia in Sweden
2011) XXIII Congress of the International Society on Thrombosis and Haemostasis In Journal of Thrombosis and Haemostasis 9. p.462-462(
- Contribution to journal › Published meeting abstract
-
Mark
Wide temperature range testing with sonoclot plateletfunction and ROTEM EXTEM/FIBTEM/APTEM test
2011) International congress thrombosis hemostasis In Journal of Thrombosis and Haemostasis 9(s2). p.91-91(
- Contribution to journal › Published meeting abstract
- 2010
-
Mark
Gas6 is complexed to soluble tyrosine kinase receptor Axl in human blood.
(
- Contribution to journal › Article
-
Mark
Bio-distribution of pharmacologically administered recombinant factor VIIa (rFVIIa)
(
- Contribution to journal › Article